When the U.S. Food and Drug Administration (FDA) issued its January 2020 safety communication warning of a possible increased risk of cancer with Belviq (lorcaserin), it said that the cause was uncertain and it could not conclude that Belviq was the … [Read more...]
MRI Patients at Risk for Gadolinium Toxicity
Since the 1980s, about 35 percent of patients who’ve received an MRI scan have received a Gadolinium-based contrast agent (GBCA). Unfortunately, GBCA safety risks have been discovered which have led to injuries, lawsuits and a new FDA class … [Read more...]
Textured Breast Implants Linked to Cancer
There’ve been reports for several months now about a specific type of cancer being linked to breast implants, and now more specific information has been made public about which implants are associated with Anaplastic Large Cell Lymphoma (ALCL), a … [Read more...]
FDA Announces Increase in Cancer Associated with Breast Implants
The Food and Drug Administration (FDA) announced in February that the incidences of breast cancer associated with breast implants is on the rise, and the FDA plans to hold a meeting on March 25 and 26 to discuss breast implant-associated anaplastic … [Read more...]
A Breakdown of the Stockert 3T Infection
When nontuberculous mycobacterium (NTM) infections started to appear in patients who had undergone open-heart surgery and other similar procedures, the FDA thought it was related to heater-cooler systems generally – not any one type in particular. … [Read more...]